News Quantified

CSLLY – csl ltd sp/adr (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

CSL Limited: Divergent Outlook For Its 2 Key Businesses [Seeking Alpha]

CSL Receives Approval in Japan for ANDEMBRY® (garadacimab) Subcutaneous (S.C.) Injection 200mg Pens, a Novel Human Anti-Activated Factor XII Monoclonal Antibody for the Prevention of Acute Attacks of Hereditary Angioedema (HAE) [Yahoo! Finance]

CSL Receives Approval in Japan for ANDEMBRY® (garadacimab) Subcutaneous (S.C.) Injection 200mg Pens, a Novel Human Anti-Activated Factor XII Monoclonal Antibody for the Prevention of Acute Attacks of Hereditary Angioedema (HAE)

European Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) [Yahoo! Finance]

European Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE)

Top News Gainers

3/13 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Jefferies Financial Group Inc from a "hold" rating to a "buy" rating. 22.0%

3/9 Australian shares dip into bear market territory [Reuters] 7.0%

4/8 Australia's CSL stands by profit guidance due to strong demand for blood products [Reuters] 6.4%

4/2 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 5.5%

4/27 Australian shares close higher on global stimulus hopes [Reuters] 3.7%

8/13 Australia shares join global rally as miners bounce, CSL gains [Reuters] 3.5%

2/18 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. 3.3%

1/10 Researchers decipher a new way that immune cells detect infections and cancers 2.9%

1/27 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%

10/14 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 2.5%

Top News Decliners

2/24 Seqirus Receives FDA Approval for FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) for Adults 65 Years and Older -5.5%

4/21 CSL Behring Announces Results from Three Analyses of Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) in Primary Immunodeficiency (PI) -4.1%

12/9 HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) -1.4%

11/15 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -1.2%

10/7 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%

2/17 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $124.00 price target on the stock. -0.7%

9/4 Australian shares end lower on global growth worries, but NZ rises [Reuters] -0.3%

7/1 CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019 -0.3%

4/9 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $110.00 price target on the stock. -0.3%

1/21 Forbes Magazine Ranks CSL Behring Among Best Employers for Diversity -0.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day